BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16848115)

  • 1. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia.
    Fideleff HL; Ruibal G; Boquete H; Pujol A; Sequera A; Sobrado P
    Horm Res; 2000; 53(1):16-9. PubMed ID: 10965215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroprolactinemia revisited: a study on 106 patients.
    Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
    J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of determining serum levels of prolactin in women with menstruation disorders].
    Starzewski J; Niespodziański K; Kowalski D; Kowalska K; Piasek G; Chlewicka B
    Przegl Lek; 1989; 46(10):728-31. PubMed ID: 2594991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.
    Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Dal Bosco F
    J Endocrinol Invest; 2003 Feb; 26(2):148-56. PubMed ID: 12739743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
    Hattori N
    J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Misleading diagnosis of hyperprolactinemia in women].
    Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
    Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
    Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
    Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
    Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Macroprolactinemia in a child].
    Weill J; Petit S; Stuckens C; Descamps Y; Racadot A; Boersma A; Ponte C
    Arch Fr Pediatr; 1990 Oct; 47(8):595-6. PubMed ID: 2078111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.
    Escobar-Morreale HF
    Fertil Steril; 2004 Dec; 82(6):1697-9. PubMed ID: 15589886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.